Works matching IS 00071188 AND DT 2024 AND VI 181 AND IP 1
Results: 12
Targeting accelerated pulmonary ageing to treat chronic obstructive pulmonary disease‐induced neuropathological comorbidities.
- Published in:
- British Journal of Pharmacology, 2024, v. 181, n. 1, p. 3, doi. 10.1111/bph.16263
- By:
- Publication type:
- Article
Lactobacillus species ameliorate membranous nephropathy through inhibiting the aryl hydrocarbon receptor pathway via tryptophan‐produced indole metabolites.
- Published in:
- British Journal of Pharmacology, 2024, v. 181, n. 1, p. 162, doi. 10.1111/bph.16219
- By:
- Publication type:
- Article
Pharmacological characterisation of erenumab, Aimovig, at two calcitonin gene‐related peptide responsive receptors.
- Published in:
- British Journal of Pharmacology, 2024, v. 181, n. 1, p. 142, doi. 10.1111/bph.16218
- By:
- Publication type:
- Article
Acetazolamide and topiramate lower intracranial pressure through differential mechanisms: The effect of acute and chronic administration.
- Published in:
- British Journal of Pharmacology, 2024, v. 181, n. 1, p. 70, doi. 10.1111/bph.16213
- By:
- Publication type:
- Article
Orexin 2 receptor antagonism sex‐dependently improves sleep/wakefulness and cognitive performance in tau transgenic mice.
- Published in:
- British Journal of Pharmacology, 2024, v. 181, n. 1, p. 87, doi. 10.1111/bph.16212
- By:
- Publication type:
- Article
Novel metallo‐β‐lactamases inhibitors restore the susceptibility of carbapenems to New Delhi metallo‐lactamase‐1 (NDM‐1)‐harbouring bacteria.
- Published in:
- British Journal of Pharmacology, 2024, v. 181, n. 1, p. 54, doi. 10.1111/bph.16210
- By:
- Publication type:
- Article
AhR–STAT3–HO‐1/COX‐2 signalling pathway may restrict ferroptosis and improve hMSC accumulation and efficacy in mouse liver.
- Published in:
- British Journal of Pharmacology, 2024, v. 181, n. 1, p. 125, doi. 10.1111/bph.16208
- By:
- Publication type:
- Article
Influence of Slco2b1‐knockout and SLCO2B1‐humanization on coproporphyrin I and III levels in rats.
- Published in:
- British Journal of Pharmacology, 2024, v. 181, n. 1, p. 36, doi. 10.1111/bph.16205
- By:
- Publication type:
- Article
Ticagrelor inverse agonist activity at the P2Y<sub>12</sub> receptor is non‐reversible versus its endogenous agonist adenosine 5´‐diphosphate.
- Published in:
- British Journal of Pharmacology, 2024, v. 181, n. 1, p. 21, doi. 10.1111/bph.16204
- By:
- Publication type:
- Article
Issue Information.
- Published in:
- British Journal of Pharmacology, 2024, v. 181, n. 1, p. 1, doi. 10.1111/bph.16116
- Publication type:
- Article
Guidance to best tools and practices for systematic reviews.
- Published in:
- British Journal of Pharmacology, 2024, v. 181, n. 1, p. 180, doi. 10.1111/bph.16100
- By:
- Publication type:
- Article
A novel EGFR inhibitor, HNPMI, regulates apoptosis and oncogenesis by modulating BCL‐2/BAX and p53 in colon cancer.
- Published in:
- British Journal of Pharmacology, 2024, v. 181, n. 1, p. 107, doi. 10.1111/bph.16141
- By:
- Publication type:
- Article